Citadel Advisors’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $969K | Buy |
139,467
+9,397
| +7% | +$65.3K | ﹤0.01% | 3346 |
|
|
2025
Q1 | $1.1M | Sell |
130,070
-14,160
| -10% | -$120K | ﹤0.01% | 3172 |
|
|
2024
Q4 | $2.02M | Buy |
144,230
+41,481
| +40% | +$581K | ﹤0.01% | 2592 |
|
|
2024
Q3 | $2.33M | Sell |
102,749
-79,566
| -44% | -$1.8M | ﹤0.01% | 2370 |
|
|
2024
Q2 | $3.69M | Buy |
182,315
+122,875
| +207% | +$2.49M | ﹤0.01% | 1916 |
|
|
2024
Q1 | $1.48M | Sell |
59,440
-235,025
| -80% | -$5.85M | ﹤0.01% | 2778 |
|
|
2023
Q4 | $5.32M | Buy |
294,465
+158,768
| +117% | +$2.87M | ﹤0.01% | 1607 |
|
|
2023
Q3 | $2.73M | Buy |
135,697
+24,541
| +22% | +$493K | ﹤0.01% | 2116 |
|
|
2023
Q2 | $2.84M | Buy |
111,156
+43,956
| +65% | +$1.12M | ﹤0.01% | 2150 |
|
|
2023
Q1 | $1.43M | Buy |
67,200
+34,210
| +104% | +$728K | ﹤0.01% | 2838 |
|
|
2022
Q4 | $977K | Sell |
32,990
-15,414
| -32% | -$456K | ﹤0.01% | 3222 |
|
|
2022
Q3 | $1.13M | Sell |
48,404
-194,930
| -80% | -$4.53M | ﹤0.01% | 3298 |
|
|
2022
Q2 | $4.08M | Buy |
+243,334
| New | +$4.08M | ﹤0.01% | 2054 |
|
|
2022
Q1 | – | Sell |
-58,187
| Closed | -$3.54M | – | 6339 |
|
|
2021
Q4 | $3.54M | Buy |
58,187
+32,840
| +130% | +$2M | ﹤0.01% | 2449 |
|
|
2021
Q3 | $1.05M | Buy |
+25,347
| New | +$1.05M | ﹤0.01% | 3719 |
|
|
2021
Q1 | – | Sell |
-29,035
| Closed | -$521K | – | 6257 |
|
|
2020
Q4 | $521K | Buy |
+29,035
| New | +$521K | ﹤0.01% | 3823 |
|